Correlation Between Salesforce and CanSino Biologics

Can any of the company-specific risk be diversified away by investing in both Salesforce and CanSino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and CanSino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Salesforce and CanSino Biologics, you can compare the effects of market volatilities on Salesforce and CanSino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of CanSino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and CanSino Biologics.

Diversification Opportunities for Salesforce and CanSino Biologics

0.79

Correlation Coefficient

Salesforce  CanSino Biologics

Poor diversification

The 3 months correlation between Salesforce and CanSino is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and CanSino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CanSino Biologics and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with CanSino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CanSino Biologics has no effect on the direction of Salesforce i.e., Salesforce and CanSino Biologics go up and down completely randomly.

Pair Corralation between Salesforce and CanSino Biologics

Assuming the 90 days trading horizon Salesforce is expected to generate 0.61 times more return on investment than CanSino Biologics. However, Salesforce is 1.64 times less risky than CanSino Biologics. It trades about 0.1 of its potential returns per unit of risk. CanSino Biologics is currently generating about 0.04 per unit of risk. If you would invest  29,445  in Salesforce on October 9, 2024 and sell it today you would earn a total of  2,685  from holding Salesforce or generate 9.12% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	97.37%
Values	Daily Returns

Salesforce  vs.  CanSino Biologics

Salesforce

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Salesforce unveiled solid returns over the last few months and may actually be approaching a breakup point.

CanSino Biologics

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in CanSino Biologics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, CanSino Biologics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Salesforce and CanSino Biologics

The main advantage of trading using opposite Salesforce and CanSino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, CanSino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CanSino Biologics will offset losses from the drop in CanSino Biologics' long position.

The idea behind Salesforce and CanSino Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.